MRT199665 - ≥99% , CAS No.1456858-57-3

CAS: 1456858-57-3 Cat. No.: M646396 Molecular Weight: 469.58 PubChem CID: 71725150
AVAILABLE TO ORDER
GRADE & PURITY ≥99%
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
 ·  off list, applied to all prices below.
Size
Status
Price
Qty
5mg
M646396-5mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$1,160.90
10mg
M646396-10mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$1,900.90
25mg
M646396-25mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$3,900.90
50mg
M646396-50mg
8-12 wks(?) Production requires sourcing of materials. We appreciate your patience and understanding.
$6,700.90
Enter a quantity for the sizes you want to add.
🧪

Why this grade

≥99% for sensitive chromatographic and analytical workflows requiring minimal baseline interference.

🌡

Storage & shipping

Store at -20°C Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.

📋

Quality documents

SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.

📚

Literature proof

Cited in 0 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.

Overview

MRT199665 is a potent and ATP-competitive, selective MARK / SIK / AMPK inhibitor with IC 50 s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14 , AMPKα1/AMPKα2 , and SIK1/SIK2/SIK3 , respectively MRT199665 causes apoptosis in MEF2C-activated human acute myeloid leukemias (AML) cells MRT199665 inhibits the phosphorylation of SIK substrate CRTC3 at S370

In Vitro

MRT199665 (1 μM; pre-treated for 1 h) increases LPS (100 ng/mL; stimulated for up to 24 h)-stimulated IL-10 mRNA and Nurr77 mRNA production, and IL-10 secretion. MRT199665 (1 nM-100 μM; 48 hours) reduces leukemia growth. MRT199665 treatment can block MEF2C S222 phosphorylation in acute myeloid leukemias (AML) cells.\nMRT199665 (10 nM-1000 nM; 12 hours) leads to a dose-dependent reduction in total and pS222 MEF2C. MRT199665 also causes a decrease of total MEF2C protein. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Western Blot AnalysisCell Line: OCI-AML2 and MOLM-13 cells Concentration: 10, 100, 500, and 1000 nM Incubation Time: 12 hours Result: Led to a dose-dependent reduction in total and pS222 MEF2C, causing more than 40% reduction in MEF2C phosphorylation at 10 nM as compared to untreated cells. Cell Proliferation AssayCell Line: Human AML cell lines OCI-AML2, MV4-11, MOLM-13 and Kasumi-1 with endogenous MEF2C phosphorylation; human AML cell lines NB-4, HEL, HL-60 and U937 lacking MEF2C Concentration: 1 nM, 10 nM, 100n M, 1 μM, 10 μM, 100μM Incubation Time: 48 hours Result: Human AML cell lines with endogenous MEF2C phosphorylation (OCI-AML2, MV4–11, MOLM-13 and Kasumi-1) were more sensitive as compared to cell lines lacking MEF2C (NB-4, HEL, HL-60 and U937), with mean IC 50 of 26±13 versus 990±29 nM, respectively.

Form:Solid

IC50& Target:MARK1 2 nM (IC 50 ) MARK2 2 nM (IC 50 ) MARK3 3 nM (IC 50 ) MARK4 2 nM (IC 50 ) SIK1 110 nM (IC 50 ) SIK2 12 nM (IC 50 ) SIK3 43 nM (IC 50 ) NUAK1 3 nM (IC 50 ) NUAK2 120 nM (IC 50 ) AMPKα1 10 nM (IC 50 ) AMPKα2 10 nM (IC 50 ) MELK 29 nM (IC 50 ) TBK1 5400 nM (IC 50 ) IKKε 7700 nM (IC 50 ) BRSK2 10000 nM (IC 50 )

Specifications

Specifications & Purity
≥99%
Biochemical and Physiological Mechanisms
MRT199665 is a potent and ATP-competitive, selective MARK / SIK / AMPK inhibitor with IC 50 s of 2/2/3/2 nM, 10/10 nM, and 110/12/43 nM for MARK1/MARK2/MARK3/MARK14 , AMPKα1/AMPKα2 , and SIK1/SIK2/SIK3 , respectively. MRT199665 causes apoptosis in ME
Storage
Store at -20°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Action Type
INHIBITOR
Purity
≥99%
Names and Identifiers
Canonical SmilesCC1(C2=CN=C(N=C2N(C1=O)C3CCC4=C3C=CC=C4O)NC5=CC=CC(=C5)CN6CCCC6)C
IUPAC Name7-[(1S)-4-hydroxy-2,3-dihydro-1H-inden-1-yl]-5,5-dimethyl-2-[3-(pyrrolidin-1-ylmethyl)anilino]pyrrolo[2,3-d]pyrimidin-6-one
InChIKeyOFIFLUFVENTCNZ-QHCPKHFHSA-N
INCHI1S/C28H31N5O2/c1-28(2)22-16-29-27(30-19-8-5-7-18(15-19)17-32-13-3-4-14-32)31-25(22)33(26(28)35)23-12-11-21-20(23)9-6-10-24(21)34/h5-10,15-16,23,34H,3-4,11-14,17H2,1-2H3,(H,29,30,31)/t23-/m0/s1
Isomeric SMILES CC1(C2=CN=C(N=C2N(C1=O)[C@H]3CCC4=C3C=CC=C4O)NC5=CC=CC(=C5)CN6CCCC6)C
PubChem CID 71725150
MeSH Entry Terms MRT199665
Molecular Weight 469.58

Documentation

📋 Safety Data Sheet (SDS)

Comprehensive hazard, handling, storage, and regulatory compliance document.

Download SDS →

✅ Certificate of Analysis (COA)

Lot-specific quality data. Enter your lot number to retrieve the exact COA.

Look up COA →

📊 Datasheet

Quick-reference summary of product specifications and applications.

View datasheet →

🔬 Specification Sheet

Full quality attributes and acceptance criteria for this grade.

View spec sheet →

Advanced Data

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClassPyrrolopyrimidines
SubclassNot available
Intermediate Tree Nodes Not available
Direct ParentPyrrolopyrimidines
Alternative Parents Indanes  Aniline and substituted anilines  Benzylamines  Phenylmethylamines  Aminopyrimidines and derivatives  Aralkylamines  1-hydroxy-4-unsubstituted benzenoids  1-hydroxy-2-unsubstituted benzenoids  Imidolactams  N-alkylpyrrolidines  Heteroaromatic compounds  Tertiary carboxylic acid amides  Pyrroles  Trialkylamines  Amino acids and derivatives  Lactams  Azacyclic compounds  Carbonyl compounds  Hydrocarbon derivatives  Organic oxides  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Indane - Pyrrolopyrimidine - Benzylamine - Phenylmethylamine - Aniline or substituted anilines - Aminopyrimidine - 1-hydroxy-4-unsubstituted benzenoid - 1-hydroxy-2-unsubstituted benzenoid - Phenol - Aralkylamine - Monocyclic benzene moiety - Imidolactam - Benzenoid - N-alkylpyrrolidine - Pyrimidine - Heteroaromatic compound - Pyrrole - Pyrrolidine - Tertiary carboxylic acid amide - Tertiary aliphatic amine - Lactam - Carboxamide group - Amino acid or derivatives - Tertiary amine - Azacycle - Carboxylic acid derivative - Amine - Organooxygen compound - Organonitrogen compound - Hydrocarbon derivative - Carbonyl group - Organic oxide - Organic oxygen compound - Organic nitrogen compound - Aromatic heteropolycyclic compound
DescriptionThis compound belongs to the class of organic compounds known as pyrrolopyrimidines. These are compounds containing a pyrrolopyrimidine moiety, which consists of a pyrrole ring fused to a pyrimidine. Pyrrole is 5-membered ring consisting of four carbon atoms and one nitrogen atom. Pyrimidine is a 6-membered ring consisting of four carbon atoms and two nitrogen centers at the 1- and 3- ring positions.
External Descriptors Not available
3D Structure
Interactive Chemical Structure Model





Certificates(CoA,COO,BSE/TSE and Analysis Chart)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Chemical and Physical Properties
SolubilityDMSO : 125 mg/mL (266.20 mM; Need ultrasonic)
Molecular Weight469.600 g/mol
XLogP34.300
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count6
Rotatable Bond Count5
Exact Mass469.248 Da
Monoisotopic Mass469.248 Da
Topological Polar Surface Area81.600 Ų
Heavy Atom Count35
Formal Charge0
Complexity770.000
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
Solution Calculators
Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.